CASP1 and neoplasm: Sorafenib was demonstrated (65) that acts through direct immune modulation involving caspase-1-related MΦ pyroptosis and the following release of inflammasome-cytokine enhanced the cytotoxicity of NK cytotoxicity for the efficient tumor cell killing.